SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-19-023026
Filing Date
2019-06-28
Accepted
2019-06-28 16:25:20
Documents
1
Period of Report
2019-06-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 10626
  Complete submission text file 0001127602-19-023026.txt   11925
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address
Business Address
DWEK RAYMOND (Reporting) CIK: 0001231617 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 19929734